Industrial and Commercial Bank of China Limited (1398.HK) vs Eli Lilly and Company (LLY)

Industrial and Commercial Bank of China Limited is one of China’s largest state-controlled commercial banks. It provides corporate banking, personal banking, wealth management, payments, and treasury services through a broad domestic and international network. The bank serves major companies, public-sector entities, small businesses, and retail customers. Its results are influenced by Chinese credit growth, interest-rate spreads, asset quality, government policy, and the health of the country’s property, infrastructure, and industrial sectors.

Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.